慢性葡萄膜炎性黄斑水肿对玻璃体内注射贝伐单抗（阿瓦斯汀）的微弱短暂反应。 - Suppr

Suppr

超能文献

Weak transient response of chronic uveitic macular edema to intravitreal bevacizumab (Avastin).

作者信息

Ziemssen Focke, Deuter Christoph M, Stuebiger Nicole, Zierhut Manfred

出版信息

Graefes Arch Clin Exp Ophthalmol. 2007 Jun;245(6):917-8. doi: 10.1007/s00417-006-0512-2. Epub 2007 Jan 12.

DOI:10.1007/s00417-006-0512-2

PMID:17219112

Abstract

摘要

相似文献

Weak transient response of chronic uveitic macular edema to intravitreal bevacizumab (Avastin).

Graefes Arch Clin Exp Ophthalmol. 2007 Jun;245(6):917-8. doi: 10.1007/s00417-006-0512-2. Epub 2007 Jan 12.

Bevacizumab and macular edema.

Ophthalmology. 2008 Mar;115(3):585. doi: 10.1016/j.ophtha.2007.10.017.

Intravitreal bevacizumab in refractory uveitic macular edema: one-year follow-up.

Eur J Ophthalmol. 2009 Jul-Aug;19(4):622-9. doi: 10.1177/112067210901900417.

Intravitreal bevacizumab for treatment of uveitic macular edema.

Ophthalmology. 2007 Aug;114(8):1574-1579.e1. doi: 10.1016/j.ophtha.2006.11.028. Epub 2007 Mar 23.

Intravitreal bevacizumab (Avastin) for the treatment of cystoid macular edema in Behçet disease.

Ocul Immunol Inflamm. 2009 Jan-Feb;17(1):59-64. doi: 10.1080/09273940802553295.

Is intravitreal bevacizumab treatment effective in diffuse diabetic macular edema?

Graefes Arch Clin Exp Ophthalmol. 2009 Nov;247(11):1575-7. doi: 10.1007/s00417-009-1132-4. Epub 2009 Jul 7.

Intravitreal bevacizumab for macular edema from idiopathic juxtafoveal retinal telangiectasis.

Ophthalmic Surg Lasers Imaging. 2007 Mar-Apr;38(2):164-6. doi: 10.3928/15428877-20070301-15.

Prognostic factors for visual outcome after intravitreal bevacizumab for macular edema due to branch retinal vein occlusion.

Graefes Arch Clin Exp Ophthalmol. 2008 Sep;246(9):1241-7. doi: 10.1007/s00417-008-0866-8. Epub 2008 Jun 11.

Triamcinolone acetonide for refractory pseudophakic cystoid macular edema after intravitreal bevacizumab.

Graefes Arch Clin Exp Ophthalmol. 2009 Mar;247(3):427-8. doi: 10.1007/s00417-008-0897-1. Epub 2008 Jul 19.

Intravitreal bevacizumab (Avastin) in the treatment of macular edema secondary to branch retinal vein occlusion.

Retina. 2007 Apr-May;27(4):419-25. doi: 10.1097/IAE.0b013e318030e77e.

引用本文的文献

Treatment Outcomes of Intravitreal Aflibercept for Uveitic Macular Edema.

Ocul Immunol Inflamm. 2024 May 17:1-8. doi: 10.1080/09273948.2024.2344709.

Intravitreal anti-vascular endothelial growth factor medications during pregnancy: current perspective.

Int Ophthalmol. 2021 Feb;41(2):743-751. doi: 10.1007/s10792-020-01610-2. Epub 2020 Oct 12.

Intravitreal therapeutic agents in noninfectious uveitic macular edema.

Indian J Ophthalmol. 2018 Aug;66(8):1060-1073. doi: 10.4103/ijo.IJO_35_18.

Intravitreal dexamethasone implant for the treatment of cystoid macular oedema associated with acute retinal necrosis.

J Ophthalmic Inflamm Infect. 2016 Dec;6(1):49. doi: 10.1186/s12348-016-0116-x. Epub 2016 Dec 23.

Intravitreal Anti-VEGF Injections in Pregnancy: Case Series and Review of Literature.

J Ocul Pharmacol Ther. 2015 Dec;31(10):605-10. doi: 10.1089/jop.2015.0056. Epub 2015 Aug 24.

[Therapy of intermediate uveitis].

Ophthalmologe. 2014 Dec;111(12):1219-32; quiz 1233-4. doi: 10.1007/s00347-014-3201-2.

The effects of intravitreal bevacizumab in infectious and noninfectious uveitic macular edema.

J Ophthalmol. 2014;2014:729465. doi: 10.1155/2014/729465. Epub 2014 Jul 21.

Ranibizumab in choroidal neovascularisation associated with ocular sarcoidosis.

BMJ Case Rep. 2013 Nov 14;2013:bcr2013010288. doi: 10.1136/bcr-2013-010288.

Initial dose of three monthly intravitreal injections versus PRN intravitreal injections of bevacizumab for macular edema secondary to branch retinal vein occlusion.

Biomed Res Int. 2013;2013:209735. doi: 10.1155/2013/209735. Epub 2013 Aug 26.

Interventions for the treatment of uveitic macular edema: a systematic review and meta-analysis.

Clin Ophthalmol. 2013;7:1109-44. doi: 10.2147/OPTH.S40268. Epub 2013 Jun 11.

本文引用的文献

Retinal pigment epithelial tear following intravitreal bevacizumab injection for neovascular age-related macular degeneration.

Acta Ophthalmol Scand. 2006 Dec;84(6):833-4. doi: 10.1111/j.1600-0420.2006.00765.x.

Intravitreal bevacizumab therapy for neovascular age-related macular degeneration: a pilot study.

Graefes Arch Clin Exp Ophthalmol. 2007 May;245(5):651-5. doi: 10.1007/s00417-006-0411-6. Epub 2006 Sep 28.

Interferon alfa-2a: a new treatment option for long lasting refractory cystoid macular edema in uveitis? A pilot study.

Retina. 2006 Sep;26(7):786-91. doi: 10.1097/01.iae.0000244265.75771.71.

Impact of macular edema on visual acuity in uveitis.

Ophthalmology. 2006 Aug;113(8):1446-9. doi: 10.1016/j.ophtha.2006.03.027.

Intravitreal bevacizumab (Avastin) for refractory pseudophakic cystoid macular edema.

Retina. 2006 Mar;26(3):356-7. doi: 10.1097/00006982-200603000-00018.

Intravitreal triamcinolone acetonide for treatment of intraocular oedematous and neovascular diseases.

Acta Ophthalmol Scand. 2005 Dec;83(6):645-63. doi: 10.1111/j.1600-0420.2005.00592.x.

Proinflammatory functions of vascular endothelial growth factor in alloimmunity.

J Clin Invest. 2003 Dec;112(11):1655-65. doi: 10.1172/JCI17712.

Medical treatment of cystoid macular edema.

Ocul Immunol Inflamm. 2002 Dec;10(4):239-46. doi: 10.1076/ocii.10.4.239.15589.

Vascular endothelial growth factor and angiopoietin-1 stimulate postnatal hematopoiesis by recruitment of vasculogenic and hematopoietic stem cells.

J Exp Med. 2001 May 7;193(9):1005-14. doi: 10.1084/jem.193.9.1005.

Vascular permeability factor: a tumor-derived polypeptide that induces endothelial cell and monocyte procoagulant activity, and promotes monocyte migration.

J Exp Med. 1990 Dec 1;172(6):1535-45. doi: 10.1084/jem.172.6.1535.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验